An aggressive rhabdomyosarcoma occurring in adults. The neoplasm is characterized by the presence of bizarre round, spindle, and polygonal cells. Clinical presentation includes a rapidly enlarging pai...
Comprehensive, easy-to-understand information about this condition
How we create this content →Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease
ADC Therapeutics SA
Other
Acerta Pharma, LLC (a member of the AstraZeneca Group)
Other
Acrotech Biopharma Inc
Other
Alexion Pharmaceuticals Inc.
Other
Alnylam Pharmaceuticals, Inc.
Other
Amgen Inc
Other
Amicus Therapeutics, Inc.
Other
Apellis Pharmaceuticals, Inc.
Other
Astellas Pharma US, Inc.
Other
Astex Pharmaceuticals, Inc.
Other
AstraZeneca Pharmaceuticals
Other
AstraZeneca Pharmaceuticals LP
Other
Auxilium Pharmaceuticals, Inc.
Other
Azurity Pharmaceuticals, Inc.
Other
BTG International Inc
Other
Bayer US LLC
Other
BeOne Medicines USA, Inc.
Other
Biogen Inc.
Other
Blueprint Medicines Corporation
Other
Bristol-Myers Squibb Company
Other
Celgene Corporation
Other
Celgene Corporation, a Bristol-Myers Squibb Company
Other
ChemoCentryx, Inc.
Other
Citius Pharmaceuticals, Inc.
Other
Daiichi Sankyo Inc.
Other
Eli Lilly and Company
Other
Epizyme, Inc.
Other
Genentech, Inc.
Other
Genetix Biotherapeutics Inc.
Other
Genmab US, Inc.
Other
Genzyme Corporation (A Sanofi Company)
Other
Geron Corporation
Other
Glaxo Wellcome Research and Development
Other
GlaxoSmithKline LLC
Other
Hoffmann-La Roche, Inc.
Other
IVAX International GmbH
Other
ImmunoGen, Inc.
Other
Impact Biomedicines, Inc. a wholly-owned subsidiary of Celgene Corporation
Other
Incyte Corporation
Other
Iovance Biotherapeutics, Inc
Other
Janssen Biotech, Inc.
Other
Jazz Pharmaceuticals, Inc.
Other
Juno Therapeutics, Inc.
Other
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Other
Karyopharm Therapeutics, Inc.
Other
Kite Pharma, Inc.
Other
Kura Oncology, Inc.
Other
Kyowa Kirin Pharmaceutical Development, Inc.
Other
Loxo Oncology, Inc.
Other
Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company
Other
MSD International Business GmbH
Other
Medunik Canada Inc
Other
Merck Sharp & Dohme LLC
Other
Novartis Pharmaceuticals Corporation
Other
Onyx Therapeutics, Inc.
Other
Orphalan SA
Other
PF PRISM C.V.
Other
PTC Therapeutics, Inc.
Other
Pfizer, Inc.
Other
Provepharm SAS
Other
Rare Disease Therapeutics, Inc.
Other
Recordati Rare Diseases, Inc.
Other
Regeneron Pharmaceuticals, Inc.
Other
Rigel Pharmaceuticals, Inc.
Other
SEAGEN INC.
Other
Sanofi-Aventis U.S. LLC
Other
Schering-Plough Research Institute
Other
Secura Bio, Inc
Other
Servier Pharmaceuticals LLC
Other
TG Therapeutics, Inc.
Other
Taiho Oncology, Inc.
Other
Takeda Pharmaceuticals U.S.A., Inc.
Other
argenx BV
Other